Product Information
PIOGLITAZONE-GLIMEPIRIDE 30-4 is a generic product labeled by Prasco Laboratories, priced at $10.9734 per EA under NDC 66993082230. Its NADAC has been published 295 times since Oct 7, 2015.
Strength
4; 30 mg/1; mg/1
Manufacturer
Prasco LaboratoriesNDC
66993082230
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021925On Market Since
8/4/2015
Pharmacological Classes
Price Statistics
The NADAC for PIOGLITAZONE-GLIMEPIRIDE 30-4 has been published 295 times since Oct 7, 2015, and over the history we have for it it has risen 15.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.9734 per EA |
|---|---|
| All-time high | $13.3590 (May 11, 2016) |
| All-time low | $7.7896 (Nov 20, 2024) |
| 52-week high | $11.4532 |
| 52-week low | $9.9491 |
| Median price | $10.7864 |
| Average price | $10.4006 |
| Largest weekly change | +40.1% (Apr 20, 2016) |
| Weeks tracked | 295 |
| Tracking since | Oct 7, 2015 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PIOGLITAZONE-GLIMEPIRIDE 30-4?
The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE-GLIMEPIRIDE 30-4, manufactured by Prasco Laboratories, is $10.9734 per EA (NDC 66993082230), effective Jun 24, 2026.
How has the price of PIOGLITAZONE-GLIMEPIRIDE 30-4 changed over time?
Over the history we have for it, the NADAC for PIOGLITAZONE-GLIMEPIRIDE 30-4 has risen 15.1%. It has been tracked across 295 weekly CMS publications since Oct 7, 2015.
What are the highest and lowest recorded NADAC prices for PIOGLITAZONE-GLIMEPIRIDE 30-4?
Since Oct 7, 2015, the NADAC for PIOGLITAZONE-GLIMEPIRIDE 30-4 has ranged from a low of $7.7896 (Nov 20, 2024) to a high of $13.3590 (May 11, 2016), with a median of $10.7864 per EA.
Are there cheaper alternatives to PIOGLITAZONE-GLIMEPIRIDE 30-4?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as PIOGLITAZONE-GLIMEPIRIDE 30-4, but none are currently priced below it.
Who manufactures PIOGLITAZONE-GLIMEPIRIDE 30-4?
PIOGLITAZONE-GLIMEPIRIDE 30-4 (NDC 66993082230) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification